3Suppliers
0Customers
1Debt Items
20Related Chains

MindWalk Holdings Corp. Suppliers

TickerNameConfidenceEvidence
BCTX BriaCell Therapeutics Corp. 90% On November 30, 2022, the Company's subsidiary, BioStrand entered into a research collaboration and license agreement with BriaCell Therapeutics Corp.
BCTX BriaCell Therapeutics Corp. 90% Reciprocal relationship from BCTX graph: Reciprocal relationship from HYFT graph: On November 30, 2022, the Company's subsidiary, BioStrand entered into a research collaboration and license agreement…
OMNIAB-INC OMNIAB-INC 90% On October 12, 2022, the Company's subsidiary, Talem entered into a multi-target license agreement with OmniAb, Inc.

MindWalk Holdings Corp. Customers

No clients on recordNo downstream customers found in our database for MindWalk Holdings Corp..

MindWalk Holdings Corp. Debt Obligations

InstrumentDescriptionConfidenceEvidence
HYFT-DEBT Debt stack $2.6M 90% Market cache reports total debt of $2.6M.

MindWalk Holdings Corp. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for MindWalk Holdings Corp..

MindWalk Holdings Corp. Ownership

HolderNameConfidenceEvidence
HYFT-OWNER-IFP-ADVISORS-INC IFP Advisors, Inc 90% 13F overlay lists IFP Advisors, Inc as top holder; 1 tracked holders.

MindWalk Holdings Corp. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ADGM Adagio Medical Holdings, Inc. 100.00 2
ATON AlphaTON Capital Corp 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
TRIB Trinity Biotech plc 100.00 2
ABBV AbbVie Inc. 100.00 2
AURA Aura Biosciences, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
CSTE Caesarstone Ltd. 100.00 2
ACIU AC Immune SA 100.00 2
SNNUF Smith & Nephew plc 100.00 2
AORT Artivion, Inc. 100.00 2
ALC Alcon Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2
FDMT 4D Molecular Therapeutics, Inc. 100.00 2